MONMOUTH JUNCTION, N.J., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the...
SAN DIEGO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed...
WALTHAM, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the...
NEWTON, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing...
Mariann Byerwalter Mariann Byerwalter joins Scipher Medicine’s Board of Advisors WALTHAM, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Scipher Medicine,...
Call to be held Wednesday, December 9, 2020, at 1:00 p.m. ESTWORCESTER, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Mustang...
Former CEO and Antios co-founder, Abel De La Rosa, Ph.D., appointed Chairman of the Board of Directors Mayes to lead...
$10 million funded immediately$25 million available upon TreT FDA approvalInterest-only period extended to September 2022WESTLAKE VILLAGE, Calif., Dec. 01, 2020...
Required lab testing complete for Biotres a novel holter patch productREDWOOD CITY, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Biotricity...
BOISE, Idaho, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Healthwise, a leader in evidence-based health education, technology, and services, announced today...
ZILXI is the First FDA Approved Minocycline Product for the Treatment of Inflammatory Lesions of Rosacea in AdultsZILXI demonstrated a favorable safety and tolerability profile for...
BASKING RIDGE, N.J., Dec. 01, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that...
SAN FRANCISCO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the retirement of K. Peony Yu,...
IJSS-published review finds that the novel biplanar expandable cage provides effective vertebral body slip or spondylolisthesis reduction and improvement in...
NORCROSS, Ga., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin...
New objective response in colon cancer triggers trial expansionLEXINGTON, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN),...
New long-term safety, efficacy, and durability data for FINTEPLA® (fenfluramine) oral solution in Dravet syndromeFull results from Phase 3 study...
Prospective study published in Journal of the American Academy of Dermatology BOCA RATON, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Sensus...
HST-001 Demonstrated Separation from Placebo at Week 18 Primary Efficacy Endpoint Assessment HST-001 Found to be Safe and Well Tolerated...
VALENCIA, Calif, and MELBOURNE, Australia, Dec. 01, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine...